AstraZeneca Pharma India Signs LoI With Strand Life Sciences
AstraZeneca Pharma India will explore healthcare collaboration in India with Strand Life Sciences, a Reliance Industries subsidiary.
Key Takeaways
- AstraZeneca Pharma India announced on November 17, 2026, that it had signed a letter of intent with Strand Life Sciences.
- The aim is to explore opportunities to collaborate in healthcare in India.
- Strand Life Sciences is a genomics research and diagnostics company owned by Reliance Industries.
- AstraZeneca Pharma India said the LoI is not a related party transaction.
- The filing did not disclose the scope or any money value of the collaboration.
Table of Contents 6 sections
AstraZeneca Pharma India Ltd said on Tuesday, November 17, 2026, that it has signed a letter of intent (LoI) with Strand Life Sciences Pvt Ltd to explore opportunities to collaborate in healthcare in India. Strand Life Sciences is a genomics research and diagnostics company and a subsidiary of Reliance Industries Ltd.
In its filing with the National Stock Exchange, AstraZeneca Pharma India said it and Strand are not related parties, and that signing the LoI does not count as a related party transaction. The filing did not give further details, such as the scope of the planned work or the areas in which the two companies may work together. AstraZeneca Pharma India made the disclosure in a filing with the National Stock Exchange (NSE).
AstraZeneca Pharma India and Strand LoI at a glance
| Detail | Value |
|---|---|
| Companies | AstraZeneca Pharma India Ltd and Strand Life Sciences Pvt Ltd |
| Type of agreement | Letter of intent (LoI) |
| Purpose | To explore opportunities to collaborate in healthcare in India |
| Strand's parent | Reliance Industries Ltd |
| Related party transaction | No, the companies are not related parties |
| Disclosed to | National Stock Exchange (NSE) |
| Announced on | November 17, 2026 |
Who AstraZeneca Pharma India and Strand Life Sciences are
AstraZeneca Pharma India is a listed subsidiary of UK-based AstraZeneca Plc. The Indian business was set up in 1979 and is headquartered in Bengaluru, Karnataka. Its key therapy areas include oncology.
Strand Life Sciences is a Bengaluru-based genomics research and diagnostics company. Reliance Industries bought a majority stake in Strand in 2021.
| When | What happened |
|---|---|
| 1979 | AstraZeneca India was set up, with its headquarters in Bengaluru |
| 2021 | Reliance Industries bought a majority stake in Strand Life Sciences |
| November 17, 2026 | AstraZeneca Pharma India announced an LoI with Strand Life Sciences to explore healthcare collaboration in India |
AstraZeneca Pharma India shares the Strand LoI on LinkedIn
AstraZeneca Pharma India also shared the news on its LinkedIn page.
The company said the details of the LoI were shared through its LinkedIn handle and its website. It has not announced any money value, timeline or specific projects linked to the LoI.
How AstraZeneca Pharma India shares moved after the news
Shares of AstraZeneca Pharma India rose more than 2% on the NSE on Tuesday after the company announced the LoI with Strand Life Sciences.
Where AstraZeneca Pharma India and Strand stand after the LoI
The LoI lets AstraZeneca Pharma India and Reliance-owned Strand Life Sciences explore working together in healthcare in India, without a related party transaction between them. The company has not shared the scope of the collaboration, and the filing gave no further details beyond the signing of the LoI.
More news
Frequently Asked Questions
What did AstraZeneca Pharma India announce?
What is AstraZeneca Pharma India?
What is Strand Life Sciences?
Who owns Strand Life Sciences?
How is the AstraZeneca Pharma India and Strand agreement structured?
How does the LoI affect related party rules for AstraZeneca Pharma India?
How much money is involved in the AstraZeneca Pharma India and Strand LoI?
How did AstraZeneca Pharma India shares react to the LoI?
When did AstraZeneca Pharma India sign the LoI with Strand?
Where did AstraZeneca Pharma India disclose the LoI?
Where did AstraZeneca Pharma India share the Strand news?
When did Reliance Industries buy into Strand Life Sciences?
More in Business
Jakson Green Signs Deal to Buy Majority Stake in Ocior Energy
Jakson Green has signed agreements to buy a majority stake in green fuel developer Ocior Energy.
Reliance Plans About Rs 15,000 Crore Investment in Biogas Plants
Reliance Industries plans to invest about $1.6 billion in new compressed biogas plants by around 2030.
Sigma Advanced Systems Forms Defence Joint Venture With EM&E
Sigma Advanced Systems has set up a joint venture with Spain's EM&E Group to make defence systems in India.
